IL107819A - 6,7-modified paclitaxels their preparation and pharmaceutical compositions containing them - Google Patents
6,7-modified paclitaxels their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL107819A IL107819A IL10781993A IL10781993A IL107819A IL 107819 A IL107819 A IL 107819A IL 10781993 A IL10781993 A IL 10781993A IL 10781993 A IL10781993 A IL 10781993A IL 107819 A IL107819 A IL 107819A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- formula
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000002456 taxol group Chemical group 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 150000004579 taxol derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98576192A | 1992-12-04 | 1992-12-04 | |
US08/128,619 US5380751A (en) | 1992-12-04 | 1993-09-28 | 6,7-modified paclitaxels |
Publications (2)
Publication Number | Publication Date |
---|---|
IL107819A0 IL107819A0 (en) | 1994-04-12 |
IL107819A true IL107819A (en) | 2000-06-29 |
Family
ID=26826766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10781993A IL107819A (en) | 1992-12-04 | 1993-12-01 | 6,7-modified paclitaxels their preparation and pharmaceutical compositions containing them |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0600517B1 (xx) |
JP (1) | JP3360186B2 (xx) |
CN (1) | CN1049433C (xx) |
AT (1) | ATE195939T1 (xx) |
AU (1) | AU668777B2 (xx) |
CA (1) | CA2109861C (xx) |
CZ (1) | CZ287599B6 (xx) |
DE (1) | DE69329327T2 (xx) |
DK (1) | DK0600517T3 (xx) |
ES (1) | ES2149188T3 (xx) |
FI (1) | FI109795B (xx) |
GR (1) | GR3034686T3 (xx) |
HU (2) | HU222347B1 (xx) |
IL (1) | IL107819A (xx) |
MX (1) | MX9307555A (xx) |
NO (1) | NO305756B1 (xx) |
NZ (1) | NZ250343A (xx) |
PL (1) | PL178135B1 (xx) |
PT (1) | PT600517E (xx) |
SG (1) | SG55014A1 (xx) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998656A (en) | 1991-09-23 | 1999-12-07 | Florida State University | C10 tricyclic taxanes |
MX9307777A (es) | 1992-12-15 | 1994-07-29 | Upjohn Co | 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. |
IL108316A (en) * | 1993-01-15 | 2006-10-31 | Univ Florida State | History of C-10 Texan and pharmaceuticals containing them |
DK0703909T3 (da) * | 1993-06-11 | 2000-09-11 | Upjohn Co | Delta6,7-taxoler, antineoplastisk anvendelse og farmaceutiske præparater indeholdende dem |
IL112412A (en) * | 1994-01-28 | 2000-02-29 | Upjohn Co | Delta 12,13-iso-taxol analogs and antineoplastic pharmaceutical compositions containing them |
US5395850A (en) * | 1994-03-10 | 1995-03-07 | Bristol-Myers Squibb Company | 6,7-epoxy paclitaxels |
GB9409131D0 (en) * | 1994-05-09 | 1994-06-29 | Erba Carlo Spa | Unsaturated taxane compounds |
FR2721025B1 (fr) * | 1994-06-09 | 1996-07-12 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
FR2721026B1 (fr) * | 1994-06-09 | 1996-07-12 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
US5840929A (en) * | 1995-04-14 | 1998-11-24 | Bristol-Myers Squibb Company | C4 methoxy ether derivatives of paclitaxel |
FR2742753B1 (fr) * | 1995-12-22 | 1998-01-30 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
US5773461A (en) * | 1996-06-06 | 1998-06-30 | Bristol-Myers Squibb Company | 7-deoxy-6-substituted paclitaxels |
US5635531A (en) * | 1996-07-08 | 1997-06-03 | Bristol-Myers Squibb Company | 3'-aminocarbonyloxy paclitaxels |
US5773464A (en) * | 1996-09-30 | 1998-06-30 | Bristol-Myers Squibb Company | C-10 epoxy taxanes |
US5977386A (en) * | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
US5902822A (en) * | 1997-02-28 | 1999-05-11 | Bristol-Myers Squibb Company | 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
US5912264A (en) * | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
US6017935A (en) * | 1997-04-24 | 2000-01-25 | Bristol-Myers Squibb Company | 7-sulfur substituted paclitaxels |
IT1317731B1 (it) * | 2000-01-18 | 2003-07-15 | Indena Spa | Tassani semisintetici con attivita' antitumorale ed antiangiogenetica. |
HUP0200759A3 (en) | 2000-02-02 | 2002-10-28 | Univ Florida State Res Found | C10 carbonate substituted taxanes as antitumor agents and pharmaceutical compositions containing them and their use |
KR20020002417A (ko) | 2000-02-02 | 2002-01-09 | 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 | 항종양제로서의 c7 카르바모일옥시 치환된 탁산 |
EP1165551B1 (en) | 2000-02-02 | 2008-07-16 | Florida State University Research Foundation, Inc. | C10 carbamoyloxy substituted taxanes as antitumor agents |
US6649632B2 (en) | 2000-02-02 | 2003-11-18 | Fsu Research Foundation, Inc. | C10 ester substituted taxanes |
MXPA03011985A (es) | 2001-06-20 | 2004-03-26 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
KR101008758B1 (ko) | 2001-09-18 | 2011-01-14 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
EP2067472A1 (en) | 2002-01-02 | 2009-06-10 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
NZ535925A (en) | 2002-04-16 | 2008-06-30 | Genentech Inc | An isolated antibody that binds to a particular polypeptide |
US7705195B2 (en) | 2002-06-07 | 2010-04-27 | Genentech, Inc. | Screening method |
EP2161283B1 (en) | 2003-11-17 | 2014-06-04 | Genentech, Inc. | Compositions comprising antibodies against CD79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin |
HN2005000054A (es) | 2004-02-13 | 2009-02-18 | Florida State University Foundation Inc | Taxanos sustituidos con esteres de ciclopentilo en c10 |
GT200500025A (es) * | 2004-02-13 | 2005-09-30 | Taxanos sustituidos con esteres de ciclopentilo en c10 | |
ES2343746T3 (es) | 2005-01-07 | 2010-08-09 | Diadexus, Inc. | Composiciones de anticuerpo ovr110 y metodos de uso. |
CA2647277A1 (en) | 2006-04-05 | 2007-11-08 | Genentech, Inc. | Method for using boc/cdo to modulate hedgehog signaling |
AU2007325283B2 (en) | 2006-11-27 | 2012-08-30 | Diadexus, Inc. | Ovr110 antibody compositions and methods of use |
ES2379413T3 (es) | 2007-02-22 | 2012-04-25 | Genentech, Inc. | Procedimientos para detectar la enfermedad inflamatoria del intestino |
CN101802012B (zh) | 2007-07-16 | 2014-08-06 | 健泰科生物技术公司 | 抗cd79b抗体和免疫偶联物及使用方法 |
US9845355B2 (en) | 2007-07-16 | 2017-12-19 | Genentech, Inc. | Humanized anti-CD79b antibodies and immunoconjugates and methods of use |
IL287292B (en) | 2008-01-31 | 2022-09-01 | Genentech Inc | and fusion antibody-drug-cd79b engineered antibodies cysteine- |
WO2009145981A1 (en) | 2008-03-31 | 2009-12-03 | Florida State University Research Foundation, Inc. | C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes |
SG174992A1 (en) | 2009-04-01 | 2011-11-28 | Genentech Inc | Anti-fcrh5 antibodies and immunoconjugates and methods of use |
WO2011050194A1 (en) | 2009-10-22 | 2011-04-28 | Genentech, Inc. | Methods and compositions for modulating hepsin activation of macrophage-stimulating protein |
CA2781887C (en) | 2009-11-30 | 2018-03-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
CA2787657A1 (en) | 2010-02-23 | 2011-09-01 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
BR112012028010A2 (pt) | 2010-05-03 | 2017-09-26 | Genentech Inc | anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero |
CN104650012A (zh) * | 2013-11-22 | 2015-05-27 | 天士力控股集团有限公司 | 一种紫杉烷类化合物 |
WO2015116902A1 (en) | 2014-01-31 | 2015-08-06 | Genentech, Inc. | G-protein coupled receptors in hedgehog signaling |
MX2020010729A (es) | 2018-04-13 | 2021-03-09 | Genentech Inc | Formulaciones de inmunoconjugado anti-cd79b estables. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4876399A (en) * | 1987-11-02 | 1989-10-24 | Research Corporation Technologies, Inc. | Taxols, their preparation and intermediates thereof |
US5175315A (en) * | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
US5015744A (en) * | 1989-11-14 | 1991-05-14 | Florida State University | Method for preparation of taxol using an oxazinone |
MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
US5227400A (en) * | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
US5272171A (en) * | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
DK0703909T3 (da) * | 1993-06-11 | 2000-09-11 | Upjohn Co | Delta6,7-taxoler, antineoplastisk anvendelse og farmaceutiske præparater indeholdende dem |
-
1993
- 1993-11-24 CA CA002109861A patent/CA2109861C/en not_active Expired - Fee Related
- 1993-11-26 NO NO934277A patent/NO305756B1/no unknown
- 1993-12-01 CZ CZ19932603A patent/CZ287599B6/cs not_active IP Right Cessation
- 1993-12-01 MX MX9307555A patent/MX9307555A/es not_active IP Right Cessation
- 1993-12-01 IL IL10781993A patent/IL107819A/xx not_active IP Right Cessation
- 1993-12-01 FI FI935381A patent/FI109795B/fi not_active IP Right Cessation
- 1993-12-02 NZ NZ250343A patent/NZ250343A/en unknown
- 1993-12-03 SG SG1996002081A patent/SG55014A1/en unknown
- 1993-12-03 HU HU9303428A patent/HU222347B1/hu not_active IP Right Cessation
- 1993-12-03 DE DE69329327T patent/DE69329327T2/de not_active Expired - Fee Related
- 1993-12-03 JP JP34215393A patent/JP3360186B2/ja not_active Expired - Fee Related
- 1993-12-03 AU AU52121/93A patent/AU668777B2/en not_active Ceased
- 1993-12-03 ES ES93119554T patent/ES2149188T3/es not_active Expired - Lifetime
- 1993-12-03 AT AT93119554T patent/ATE195939T1/de not_active IP Right Cessation
- 1993-12-03 EP EP93119554A patent/EP0600517B1/en not_active Expired - Lifetime
- 1993-12-03 PT PT93119554T patent/PT600517E/pt unknown
- 1993-12-03 DK DK93119554T patent/DK0600517T3/da active
- 1993-12-03 CN CN93120068A patent/CN1049433C/zh not_active Expired - Fee Related
- 1993-12-03 PL PL93301305A patent/PL178135B1/pl not_active IP Right Cessation
- 1993-12-03 HU HU0103602A patent/HU221817B1/hu not_active IP Right Cessation
-
2000
- 2000-10-26 GR GR20000402373T patent/GR3034686T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ287599B6 (en) | 2001-01-17 |
ATE195939T1 (de) | 2000-09-15 |
NO305756B1 (no) | 1999-07-19 |
HU221817B1 (hu) | 2003-01-28 |
FI935381A (fi) | 1994-06-05 |
CZ260393A3 (en) | 1994-07-13 |
CN1094041A (zh) | 1994-10-26 |
NZ250343A (xx) | 1996-11-26 |
AU668777B2 (en) | 1996-05-16 |
HU222347B1 (hu) | 2003-06-28 |
DK0600517T3 (da) | 2000-10-30 |
GR3034686T3 (en) | 2001-01-31 |
JPH06211823A (ja) | 1994-08-02 |
FI935381A0 (fi) | 1993-12-01 |
PL178135B1 (pl) | 2000-03-31 |
HU9303428D0 (en) | 1994-04-28 |
DE69329327T2 (de) | 2001-04-05 |
EP0600517A1 (en) | 1994-06-08 |
NO934277D0 (no) | 1993-11-26 |
CA2109861C (en) | 1999-03-16 |
FI109795B (fi) | 2002-10-15 |
AU5212193A (en) | 1994-06-16 |
HUT65640A (en) | 1994-07-28 |
MX9307555A (es) | 1995-01-31 |
SG55014A1 (en) | 1998-12-21 |
CA2109861A1 (en) | 1994-06-05 |
PT600517E (pt) | 2000-12-29 |
NO934277L (no) | 1994-06-06 |
IL107819A0 (en) | 1994-04-12 |
DE69329327D1 (de) | 2000-10-05 |
PL301305A1 (en) | 1994-06-13 |
ES2149188T3 (es) | 2000-11-01 |
EP0600517B1 (en) | 2000-08-30 |
JP3360186B2 (ja) | 2002-12-24 |
CN1049433C (zh) | 2000-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL107819A (en) | 6,7-modified paclitaxels their preparation and pharmaceutical compositions containing them | |
IL106453A0 (en) | Deoxy taxols and pharmaceutical compositions containing them | |
HU9301902D0 (en) | Fluorinic derivatives of taxole, method for producing them and anti-cancer preparatives containing said compounds as active agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |